APA (7th ed.) Citation

Pieper, M., Scheffold, C., Duwe, S., Rossig, C., Bisping, G., Stelljes, M., . . . Kienast, J. (2006). Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells. Leukemia (08876924), 20(4), 729. https://doi.org/10.1038/sj.leu.2404114

Chicago Style (17th ed.) Citation

Pieper, M., et al. "Immunotherapy of B-cell Malignancies with Genetically Engineered Human CD8+ Natural Killer T Cells." Leukemia (08876924) 20, no. 4 (2006): 729. https://doi.org/10.1038/sj.leu.2404114.

MLA (9th ed.) Citation

Pieper, M., et al. "Immunotherapy of B-cell Malignancies with Genetically Engineered Human CD8+ Natural Killer T Cells." Leukemia (08876924), vol. 20, no. 4, 2006, p. 729, https://doi.org/10.1038/sj.leu.2404114.